Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control

BACKGROUND: A continuous relationship between reductions in low-density lipoprotein cholesterol (LDL-C) and major adverse cardiovascular events (MACE) has been observed in statin and ezetimibe outcomes trials down to achieved levels of 54 mg/dL. However, it is uncertain whether this relationship ext...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray, Kausik K., Ginsberg, Henry N., Davidson, Michael H., Pordy, Robert, Bessac, Laurence, Minini, Pascal, Eckel, Robert H., Cannon, Christopher P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147039/
https://www.ncbi.nlm.nih.gov/pubmed/27777279
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147039/
https://www.ncbi.nlm.nih.gov/pubmed/27777279
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024604

Ejemplares similares